Showing 1 - 4 of 4
Persistent link: https://www.econbiz.de/10012008043
Persistent link: https://www.econbiz.de/10012182277
The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost-effectiveness studies of branded drugs in the USA, the...
Persistent link: https://www.econbiz.de/10013366987
Persistent link: https://www.econbiz.de/10000338188